Palliative treatments for advanced osteosarcoma

Journal of B.U.ON.

Volumn 17, Issue 3, 2012, Pages 436-445

  Mavrogenis, Andreas F ^a   Rossi, G ^b   Palmerini, E ^b   Errani, C ^b   Rimondi, E ^b   Ruggieri, R ^b   Soucacos, R N ^a   Papagelopoulos, P J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Advanced osteosarcoma; Palliative treatment

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; GELFOAM; GEMCITABINE; IFOSFAMIDE; LEXIDRONAM SAMARIUM SM 153; MELPHALAN; MESNA; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADVANCED CANCER; ARTIFICIAL EMBOLISM; BONE METASTASIS; BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CRYOABLATION; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; HEAVY ION RADIATION; HUMAN; INCIDENCE; LIMB PERFUSION; LIMB SALVAGE; LUNG METASTASIS; LYMPH NODE METASTASIS; OSTEOSARCOMA; PHOTON THERAPY; PRIMARY TUMOR; PROTON THERAPY; QUALITY OF LIFE; REVIEW; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

BONE NEOPLASMS; CATHETER ABLATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EMBOLIZATION, THERAPEUTIC; HUMANS; OSTEOSARCOMA; PALLIATIVE CARE;

EID: 84867567380     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Wittig JC, Bickels J, Priebat D et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 2002; 65: 1123-1132.
2. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3-13.
3. Link MP, Goorin AM, Miser AW et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314: 1600-1606. (Pubitemid 16118216)
4. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 1987; 5: 21-26. (Pubitemid 17007852)
5. Bacci G, Ferrari S, Mercuri M et al. Neoadjuvant chemotherapy for extremity osteosarcoma-preliminary results of the Rizzoli's 4th study. Acta Oncol 1998;37:41-48. (Pubitemid 28179799)
6. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006; 32: 423-436. (Pubitemid 44309249)
7. Errani C, Longhi A, Rossi G et al. Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther 2011; 11: 217-227.
8. Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 1997; 15: 363-367. (Pubitemid 27020594)
9. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop Relat Res 1998; 348: 196-207. (Pubitemid 28160824)
10. Ha PK, Eisele DW, Frassica FJ, Zahurak ML, McCarthy EF. Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope 1999; 109: 964-969. (Pubitemid 29269023)
11. Bielack SS, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol 1999; 17: 1164-1174. (Pubitemid 29162940)
12. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994; 12: 423-431. (Pubitemid 24056419)
13. Bacci G, Briccoli A, Mercuri M et al. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy. J Chemother 1998; 10: 69-76. (Pubitemid 28092412)
14. Bacci G, Briccoli A, Longhi A et al. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol 2005; 44: 748-755. (Pubitemid 41547077)
15. Jaffe N, Bruland ØS, Bielack SS (Eds): Pediatric and Adolescent Osteosarcoma. Springer, NY, USA, 2009.
16. Kempf-Bielack B, Bielack SS, Jórgens H et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 2005; 23: 559-568. (Pubitemid 46224233)
17. Grignani G, Palmerini E, Dileo P et al.A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. Ann Oncol 2011 [Epub ahead of print].
18. Bacci G, Mercuri M, Briccoli A et al. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer 1997; 79: 245-254. (Pubitemid 27029888)
19. Mialou V, Philip T, Kalifa C et al. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome - the French pediatric experience. Cancer 2005; 104: 1100-1109. (Pubitemid 41170240)
20. Daw NC, Billups CA, Rodriguez-Galindo C et al. Metastatic osteosarcoma. Cancer 2006; 106: 403-412.
21. Bacci G, Rocca M, Salone M et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 2008; 98: 415-420.
22. Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol 2009; 10: 82-93.
23. Merimsky O, Kollender Y, Inbar M, Meller I, Bickels J. Palliative treatment for advanced or metastatic osteosarcoma. Isr Med Assoc J 2004; 6: 34-38. (Pubitemid 38094376)
24. Malawer MM, Link MP, Donaldson SS. Sarcomas of bone. In: DeVita VT, Hellman SI, Rosenberg SA (Eds): Cancer. Principles and Practice of Oncology (5th Edn). Philadelphia: Lippincott-Raven, 1997, pp 1731-1852.
25. Kawai A, Healey JH, Boland PJ, Lin PP, Huvos AG, Meyers PA. Prognostic factors for patients with sarcomas of the pelvic bones. Cancer 1998; 82: 851-859. (Pubitemid 28104163)
26. Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev 2009; 28: 247-263.
27. Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol 2007; 19: 341-346. (Pubitemid 46883523)
28. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer 2005; 41: 2836-2845. (Pubitemid 41713121)
29. Harris MB, Cantor AB, Goorin AM et al. Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study. Med Pediatr Oncol 1995; 24: 87-92.
30. Kebudi R, Görgün O, Ayan I. Oral etoposide for recurrent/progressive sarcomas of childhood. Pediatr Blood Cancer 2004; 42: 320-324. (Pubitemid 38327624)
31. Merimsky O, Meller I, Flusser G et al. Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study. Cancer Chemother Pharmacol 2000; 45: 177-181. (Pubitemid 30090250)
32. Meyer WH, Schell MJ, Kumar AP et al. Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival. Cancer 1987; 59: 374-379. (Pubitemid 17232906)
33. Pastorino U, Gasparini M, Tavecchio L et al. The contribution of salvage surgery to the management of childhood osteosarcoma. J Clin Oncol 1991; 9: 1357-1362.
34. Skinner KA, Eilber FR, Holmes EC, Eckardt J, Rosen G. Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma. Arch Surg 1992; 127: 1065-1071.
35. Tabone MD, Kalifa C, Rodary C, Raquin M, Valteau-Couanet D, Lemerle J. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol 1994; 12: 2614-2620. (Pubitemid 24379647)
36. Ward WG, Mikaelian K, Dorey F et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994; 12: 1849-1858. (Pubitemid 24349387)
37. Briccoli A, Rocca M, Salone M, Guzzardella GA, Balladelli A, Bacci G. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005. Surg Oncol 2010; 19: 193-199.
38. Ferrari S, Briccoli A, Mercuri M et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol 2003; 21: 710-715. (Pubitemid 46621907)
39. Baram TZ, van Tassel P, Jaffe NA. Brain metastases in osteosarcoma: incidence, clinical and neuroradiological findings and management options. J Neurooncol 1988; 6: 47-52.
40. Bickels J, Manusama ER, Gutman M et al. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity. Eur J Surg Oncol 1999; 25: 509-514. (Pubitemid 29462341)
41. Niedeggen A, Weis J, Mertens R, Röther J, Bröcheler J. Unusually long survival time after resection and irradiation of a brain metastasis from osteosarcoma. Neurosurg Rev 1990; 13: 247-252. (Pubitemid 20337102)
42. Saab R, Rao BN, Rodriguez-Galindo C, Billups CA, Fortenberry TN, Daw NC. Osteosarcoma of the pelvis in children and young adults: the St. Jude Children's Research Hospital experience. Cancer 2005; 103: 1468-1474. (Pubitemid 40410744)
43. Bacci G, Longhi A, Cesari M, Versari M, Bertoni F. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer 2006; 106: 2701-2706.
44. Nathan SS, Gorlick R, Bukata S et al. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Cancer 2006; 107: 1607-1616. (Pubitemid 44546922)
45. Malawer MM, Buch RG, Thompson WE, Sugarbaker PH. Major amputations done with palliative intent in the treatment of local bony complications associated with advanced cancer. J Surg Oncol 1991; 47: 121-130.
46. Merimsky O, Rollender Y, Inbar M, Chaitchik S, Meller I. Palliative major amputation and quality of life in cancer patients. Acta Oncol 1997; 36: 151-157. (Pubitemid 27168752)
47. Blattmann C, Oertel S, Schulz-Ertner D et al. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. BMC Cancer 2010; 10: 96-102.
48. Gutman M, Inbar M, Lev-Shlush D et al. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 1997; 79: 1129-1137. (Pubitemid 27118210)
49. Loeb DM, Garrett-Mayer E, Hobbs RF et al. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer 2009; 115: 2514-2522.
50. Mahajan A, Woo SY, Kornguth DG et al. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer 2008; 50: 976-982. (Pubitemid 351500174)
51. Hundsdoerfer P, Albrecht M, Róhl U, Fengler R, Kulozik AE, Henze G. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma. Eur J Cancer 2009; 45: 2447-2451.
52. Anderson P, Aguilera D, Pearson M, Woo S. Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents. Cancer Control 2008; 15: 38-46. (Pubitemid 351481990)
53. Whelan JS, Burcombe RJ, Janinis J, Baldelli AM, Cassoni AM. A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol 2002; 13: 23-30. (Pubitemid 34436718)
54. Tan ML, Choong PF, Dass CR. Osteosarcoma: Conventional treatment vs. gene therapy. Cancer Biol Ther 2009; 8 :106-117.
55. Anderson P, Nuñez R. Samarium lexidronam (153Sm-EDT-MP): skeletal radiation for osteoblastic bone metastases and osteosarcoma. Expert Rev Anticancer Ther 2007; 7: 1517-1527. (Pubitemid 350303011)
56. DeLaney TF, Liebsch NJ, Pedlow FX et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 2009; 74: 732-739.
57. Ciernik IF, Niemierko A, Harmon DC et al. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer 2011; 117: 4522-4530.
58. Börüban S, SancakT, Yildiz Y, Saǧlik Y. Embolization of benign and malignant bone and soft tissue tumors of the extremities. Diagn Interv Radiol 2007; 13: 164-171. (Pubitemid 47354352)
59. Chuang VP, Benjamin R, Jaffe N et al. Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR Am J Roentgenol 1982; 139: 1065-1069. (Pubitemid 13201952)
60. Zhang HJ, Yang JJ, Lu JP et al. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity. Cardiovasc Intervent Radiol 2009; 32: 672-678.
61. Chuang VP, Soo CS, Wallace S, Benjamin RS. Arterial occlusion: management of giant cell tumor and aneurysmal bone cyst. AJR Am J Roentgenol 1981; 136: 1127-1130. (Pubitemid 12236557)
62. Chuang VP. Angiographic contributions to the management of advanced cancer. AJR Am J Roentgenol 1984; 142: 385-388. (Pubitemid 14182100)
63. Rossi G, Mavrogenis AF, Rimondi E et al. Selective arterial embolisation for bone tumours: experience of 454 cases. Radiol Med 2011; 116: 793-808.
64. Owen RJ. Embolization of musculoskeletal tumors. Radiol Clin North Am 2008; 46: 535-543, vi.
65. Gottfried ON, Schloesser PE, Schmidt MH, Stevens EA. Embolization of metastatic spinal tumors. Neurosurg Clin North Am 2004; 15: 391-399. (Pubitemid 39278434)
66. Krauel L, Albert A, Mora J et al. Use of angioembolization as an effective technique for the management of pediatric solid tumors. J Pediatr Surg 2009; 44: 1848-1855.
67. Mavrogenis AF, Rossi G, Rimondi E, Papagelopoulos PJ, Ruggieri P. Embolization of bone tumors. Orthopedics 2011; 34: 303-310.
68. Breslau J, Eskridge JM. Preoperative embolization of spinal tumors. J Vasc Interv Radiol 1995; 6: 871-875.
69. Vlahos L, Benakis V, Dimakakos P, Dimopoulos C, Pontifex G. A comparative study of the degree of arterial recanalization in kidneys of dogs following transcatheter embolization with eight different materials. Eur Urol 1980; 6: 180-185. (Pubitemid 10102972)
70. Hansen ME, Kadir S. Elective and emergency embolotherapy in children and adolescents. Efficacy and safety. Radiologe 1990; 30: 331-336. (Pubitemid 20241867)
71. Chu JP, Chen W, Li JP et al. Clinicopathologic features and results of transcatheter arterial chemoembolization for osteosarcoma. Cardiovasc Intervent Radiol 2007; 30: 201-206. (Pubitemid 46147107)
72. Jaffe N, Knapp J, Chuang VP et al. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDDP). Angiographic, pathologic, and pharmacologic studies. Cancer 1983; 51: 402-407. (Pubitemid 13185366)
73. Stewart DJ, Benjamin RS, Zimmerman S et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res 1983; 43: 917-920. (Pubitemid 13193903)
74. Rao BN, Rodriguez-Galindo C. Intra-arterial cisplatin in osteosarcoma: same question, different answer. Ann Surg Oncol 2003; 10: 481483.
75. Nagata Y, Mitsumori M, Okajima K et al. Transcatheter arterial embolization for malignant osseous and soft tissue sarcomas. II. Clinical results. Cardiovasc Intervent Radiol 1998; 21: 208-213. (Pubitemid 28257682)
76. Wang MQ, Dake MD, Wang ZP, Cui ZP, Gao YA. Isolated lower extremity chemotherapeutic infusion for treatment of osteosarcoma: experimental study and preliminary clinical report. J Vasc Interv Radiol 2001; 12: 731-737. (Pubitemid 32536673)
77. Anderson JH, Gianturco C, Wallace S. Experimental transcatheter intraarterial infusion-occlusion chemotherapy. Invest Radiol 1981; 16: 496-500. (Pubitemid 12250594)
78. Kato T, Nemoto R, Mori H, Takahashi M, Tamakawa Y, Harada M. Arterial chemoembolization with microencapsulated anticancer drug. An approach to selective cancer chemotherapy with sustained effects. JAMA 1981; 245: 1123-1127. (Pubitemid 11095958)
79. Chuang VP, Wallace S. Chemoembolization: transcatheter management of neoplasms. JAMA 1981; 245: 1151-1152. (Pubitemid 11095966)
80. Cullen JW, Jamroz BA, Stevens SL et al. The value of serial arteriography in osteosarcoma: delivery of chemotherapy, determination of therapy duration, and prediction of necrosis. J Vasc Interv Radiol 2005; 16: 1107-1119. (Pubitemid 41177124)
81. Thanos L, Mylona S, Galani P et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol 2008; 37: 189-194.
82. Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases - why cryoablation? Skeletal Radiol 2009; 38: 835-839.
83. Ding JH, Chua TC, Glenn D, Morris DL. Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases. Interact Cardiovasc Thorac Surg 2009; 9: 1051-1053.
84. Nakamura T, Matsumine A, Yamakado K et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected]. Cancer 2009; 115: 3774-81. Erratum in: Cancer 2009; 115: 4041.
85. Jones RL, McCall J, Adam A et al. Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma. Eur J Surg Oncol 2010; 36: 477-482.
86. Callstrom MR, Charboneau JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol 2007; 10: 120-131. (Pubitemid 350216510)
87. Callstrom MR, Atwell TD, Charboneau JW et al. Painful metastases involving bone: percutaneous image-guided cryoablation - prospective trial interim analysis. Radiology 2006; 241: 572-580. (Pubitemid 44632905)
88. Ward E, Munk PL, Rashid F, Torreggiani WC. Musculoskeletal interventional radiology: radiofrequency ablation. Radiol Clin North Am 2008; 46: 599-610, vi-vii.
89. Rybak LD. Fire and ice: thermal ablation of musculoskeletal tumors. Radiol Clin North Am 2009; 47: 455-469.
90. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 2007; 25: 978-986. (Pubitemid 350002864)
91. Gillams AR. Image guided tumour ablation. Cancer Imaging 2005; 5: 103-109.